SCHEMBL24845

SCHEMBL24845

C=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8434 1.00
SCHEMBL8585535 1.00
SCHEMBL8519870 0.87
Iodide SCHEMBL6028354 0.87
SCHEMBL621867 0.87
SCHEMBL9436638 0.87
Hydrochloric Acid SCHEMBL4432819 0.87
Hydrochloric Acid SCHEMBL1476890 0.87
Iodide SCHEMBL8990166 0.87
Ammonia Solution, Strong SCHEMBL7071170 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12838 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113924492-B Detection of microbial endotoxin in oral samples using an aptamer 宝洁公司 2024-07-16 CN claimed
CN-118355123-A Aptamer for personal healthcare applications 宝洁公司 2024-07-16 CN claimed
CN-118339295-A Aptamer for personal healthcare applications 宝洁公司 2024-07-12 CN claimed
US-11946050-B2 Polynucleotide compositions and methods for gene expression regulations APTAH BIO, INC. (US) 2024-04-02 US claimed
WO-2023220744-A2 SINGLE-STRANDED LOOP OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2023-11-16 WO claimed
WO-2023152371-A1 GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA PROQR THERAPEUTICS II B.V. (NL) 2023-08-17 WO claimed
US-20230257745-A1 Circular siRNAs BANK OF AMERICA, N.A. 2023-08-17 US claimed
EP-4183399-A1 METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST EXON 52 OF THE HUMAN DUCHENNE MUSCULAR DYSTROPHY GENE Academisch Ziekenhuis Leiden (NL) 2023-05-24 EP claimed
CN-115996729-A Aptamer for personal healthcare applications 宝洁公司 2023-04-21 CN claimed
US-20230039928-A1 Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt disease PROQR THERAPEUTICS II B.V. (NL) 2023-02-09 US claimed
EP-0579754-A1 USE OF AMINES TO SENSITIZE MULTIDRUG-RESISTANT CELLS THE UPJOHN COMPANY (US) 1994-01-26 EP claimed
EP-0294686-B1 PROCESS FOR THE PREPARATION OF DIARYLIMINOCARBONATES BASF Aktiengesellschaft (DE) 1992-12-09 EP claimed
WO-1992018089-A2 USE OF STEROIDAL AND NON-STEROIDAL AMINES TO SENSITIZE MULTIDRUG-RESISTANT CELLS THE UPJOHN COMPANY (US) 1992-10-29 WO claimed
EP-0472670-A1 SYMMETRICAL BIPEPTIDES INCLUDING A POLYALKYLENE-GYLCOL GROUP, METHOD OF PREPARATION AND USE IN PROTEASE DETERMINATION. SERBIO (FR) 1992-03-04 EP claimed
EP-0039051-B1 MANNICH-BASE HYDROXAMIC ACID PRODRUGS FOR THE IMPROVED BIOAVAILABILITY OF NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, A PROCESS FOR PREPARING AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM MERCK & CO. INC. (US) 1985-07-24 EP claimed
EP-0055444-B1 TRISUBSTITUTED PYRIMIDO(5,4-D)PYRIMIDINES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1985-03-20 EP claimed
US-4365062-A BACTERICIDAL ANTIBIOTICS RHONE-POULENC INDUSTRIES (FR) 1982-12-21 US claimed
US-4307230-A ANTIBIOTICS RHONE-POULENC INDUSTRIES (FR) 1981-12-22 US claimed
US-RE30731-E Enkephalin analogues Hudson, Derek (GB) 1981-09-01 US claimed
US-4198398-A Enkephalin analogues HUDSON DEREK (GB) 1980-04-15 US claimed